Oxandrin

   
Google
 
Web NewDrugInformation.com

Oxandrin


Drug - Oxandrin
The trade name of the product as shown on the labeling.

Dosage - TABLET; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Oxandrolone
Multiple ingredients are in alphabetical order.

Strength - 2.5MG
The potency of the active ingredient(s), Oxandrolone. May repeat for multiple part products.

Applicant - SAVIENT PHARMS
The firm name holding legal responsibility for Oxandrin. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 013718
The FDA assigned number to Oxandrin. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Oxandrin. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Approved Prior to Jan 1, 1982
The date Oxandrin was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Oxandrin. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Oxandrin is in. Format is RX, OTC, DISCN.

Applicant Full Name - Savient Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Oxandrin.

Oxandrin